A graduate of Uppsala University in Sweden, Robert Gadimian has been working in the pharmaceutical industry for more than 20 years. He started out in pharmacokinetics, working with Pharmacia and Upjohn in Sweden, and went on to hold such titles as global regulatory head for Abbott Laboratories, global labeling liaison for Amgen, and senior director of regulatory affairs at Syner-G Pharma Consulting. Robert Gadimian leverages this experience in pharmaceutical regulation to serve as president of Perceptive Regulatory Consulting, a regulatory affairs company based in California that helps clients gain approval from health authorities around the world. In addition to leading Perceptive Regulatory Consulting, Mr. Gadimian is the president of Rophe Pharma, a virtual start-up company that finds innovative uses for approved drugs. The company, which he founded, works with hospital research institutions, pharmaceutical consultants and experts, and contract research organizations to assist with the development of new ideas to boost wellness. So far, Robert Gadimian and his C corporation have been involved in the creation of a topical hair growth compound and a treatment for diabetic foot ulcers. It has also had a hand in the development and patent of multiple compounds that treat a range of diseases, including cystic fibrosis.